MedPath
NMPA Approval

Telmisartan and Amlodipine Tablets

国药准字H20249564

December 1, 2024

Drug Information

替米沙坦氨氯地平片

片剂

每片含替米沙坦80 mg与苯磺酸氨氯地平 5 mg(以氨氯地平计)

化学药品

December 1, 2024

Company Information

Applicant Company

山西省晋中市山西示范区晋中开发区汇通产业园区开发区机械园

Manufacturing Company

山西省晋中市山西示范区晋中开发区汇通产业园区开发区机械园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

替米沙坦氨氯地平片 - NMPA 批准文号 | MedPath